Introduction: Transfemoral approach (TFA) may be preferred access site in order to facilitate complex percutaneous procedures such as rotational atherectomy (RA).
| INTRODUCTION
Rotational atherectomy (RA) is a method of treatment of highly calcified or fibrotic lesions that cannot be treated with traditional percutaneous coronary intervention (PCI). 1 Transfemoral approach (TFA) may be preferred in order to facilitate complex procedures such as RA, obtain proper backup and therefore achieve procedural success.
Additionally, the introduction of transradial approach (TRA) into daily practice is initially a challenging and demanding technique and a learning curve is longer. On the other hand, there is a growing evidence that TRA for PCI is safe, effective and associated with lower access site complication rates and even lower mortality, including complex procedures like in acute coronary syndromes and cardiogenic shock. [2] [3] [4] [5] The data comparing TRA to TFA in RA procedures is limited and mainly short-term, including recent conference abstracts and suggesting equivalent efficacy and safety of radial access site. [6] [7] [8] [9] Despite encouraging results the use of TRA in a real-world is still relatively low, reaching 50-80% in unselected population undergoing PCI 10 and, moreover, reaching only 20-30% in registries concerning PCI with the use of RA. [11] [12] [13] The development of novel catheters, vascular sheaths and supplementary devices for TRA is also noticeable, enabling to perform complex procedures and introduction of RA burrs with success.
Therefore, the aim of the study was to assess in-hospital and 1-year outcomes in patients undergoing RA using TRA, in comparison to RA using TFA in all-comers population.
2 | METHODS
| Study population
In the single center observational study we analyzed the data of all consecutive patients who underwent PCI with RA in our institution from January 2010 to October 2015. During this time an average of 1750 PCIs per year were performed and an average of around 2% of all cases were performed with accompanying RA. In our center seven independent PCI operators are working, including two independent RA operators. There were no exclusion criteria. Baseline demographic, clinical characteristics, and detailed procedural data were collected, including indication for procedure, urgency, and lesion characteristics with basic quantitative coronary angiography (QCA) parameters. All patients were subsequently divided into two groups based on vascular approach for PCI: TRA group and TFA group.
Preprocedural disqualification from coronary artery bypass grafting (CABG), if necessary, was undertaken by the local HeartTeam. Information on all complications after each intervention, inhospital and outcome major adverse cardiovascular events (MACE) was collected. All patients gave informed consent for the procedure.
Follow-up data regarding all-cause mortality and recurrent hospitalizations and MACE was obtained from the Polish National Health Fund database, therefore no patient was lost to follow-up. The study protocol was accepted by local Bioethics Committee and was in accordance with the declaration of Helsinki. 
| Study and endpoints definitions

| Procedure
RA procedure was performed using standard Boston Scientific
Rotablator system (Boston Scientific, Marlborough, MA). All procedures were performed by experienced rotablator operators with multiannual experience in PCI and with skills for both radial and femoral approaches.
The choice of the access site was at the discretion of the operator. With both radial and femoral access 6F vascular sheaths and guiding catheters were used as default. When burr larger than 1.75 mm was needed 7F
sheath and catheter were used for femoral access and 6.5F sheathless guiding catheter was used for radial access. Burr speeds were between 140 000 and 180 000 rpm with a run duration to about 20-30 s. In all procedures an intracoronary continuous infusion of heparin, verapamil, and isosorbite dinitrate via the burr sheath was used. Heparin was given to maintain an activated clotting time >250 s. All patients were pretreated with aspirin and clopidogrel, except three patients treated with ticagrelor and one treated with prasugrel. In the TRA group, the vascular sheath was removed immediately following interventional procedures and hemostasis was achieved using a hemostatic bandage.
In the TFA group, the vascular sheath was removed 4-6 h following the procedure, when the activated clotting time was <180 s. The hemostasis was achieved using manual pressure and subsequently using external compression bandage. In-hospital treatment in both groups was conducted according to current standards, including adequate pharmacotherapy in patients with comorbidities like heart failure, atrial fibrillation, diabetes mellitus, and was left to the discretion of physicians in charge of the patients.
| Statistical analysis
Continuous variables with normal distribution are presented as mean ± standard deviation, continuous variables with skewed distribution are presented as median with interquartile range and categorical variables are presented as numbers and percentages. For continuous variables intergroup differences were compared using Student's t-test or the Mann-Whitney U test, depending on the type of distribution. The χ 2 test was used to compare categorical variables.
Univariate Cox proportional hazard model was used to determine the predicting factors of access site selection. Survival and event-free survival curves were created using the Kaplan-Meier method. Differences in survival and event-free survival rates were compared using the log-rank test. A P-value <0.05 was considered statistically significant. All statistical analyses were performed using the Statistica 10.0 (StatSoft/Tibco, Palo Alto, CA) software.
3 | RESULTS
| Patient characteristics
From January 2010 to October 2015, 177 patients underwent RA in our center. All patients were included in the registry. In 123 (69%)
patients the procedure was performed via the radial access site and in 54 (31%) via the femoral access site. Complete demographics, comorbidities, and laboratory results of both groups are presented in Table 1 . Except for male sex (73% vs 57%, P = 0.04) and clinical risk calculated with the logistic Euroscore II model (2.1% vs 3.2%, P = 0.02)
there were no differences in common cardiovascular risk factors.
| Procedure characteristics
There was no statistical difference in procedural success between radial and femoral access sites (95% vs 87%, P = 0.07) with even a trend in favor of TRA. Procedure characteristics are summarized in Table 2 .
RA in chronic total occlusions was more often performed via TFA (22% vs 8%, P = 0.001). When RA was performed via TRA smaller burrs (1.4 ± 0.2 mm vs 1.5 ± 0.2 mm, P = 0.004), less often pacing wire insertion (3% vs 30%, P < 0.01) and lower amount of contrast volume (250 mL vs 280 mL with proceeding coronary angiography, P = 0.009) were used. Hospital stay after the procedure was also shorter in TRA (2 days vs 3 days, P = 0.004). There were no differences in procedure and fluoroscopy time, radiation exposure, and other procedural characteristics.
| In-hospital and 1-year outcome
Periprocedural complication rates were low, without differences in both groups and are presented in Table 3 and on Figure 1 , along with postprocedural in-hospital and 1-year adverse events. Patients who underwent RA with TFA had significantly higher rate of major access site bleedings during the hospital stay (13% vs 1%, P = 0.001). There were no differences in mortality and other adverse events both inhospital and during 1-year observation. comparison demonstrated no significant differences in survival rate and MACE-free survival rate in both study groups.
| Predictors of radial access site selection
Since it was not a randomized trial, the choice of the access site was at the discretion of the operators and therefore we investigated which clinical factors favored the choice of radial access site. Univariate logistic regression analysis showed that male sex was the only predictor of radial access site selection. The results are presented in Table 4 . The most important outcome difference between TRA and TFA group was the rate of major access site bleedings, significantly more frequent by femoral access site (P = 0.001, Figure 1 ). A similar difference was seen in the comparison of Yin et al 9 and was numerically higher, however statistically not significant in two other papers concerning access site in RA. 6, 8 In spite of similar in-hospital and 1-year survival of our both study groups, access site complications remain an acknowledged predictor of adverse procedural success and patients' outcome. 18 Importantly, some other procedural aspects were also in favor of TRA. Total contrast volume used via TRA was significantly lower than via TFA that was not seen in other RA studies.
| DISCUSSION
Although the rate of CIN was similar in both study groups, the positive impact of radial access in overall PCI on kidney injury has been observed. 19 Additionally, the use of TRA for RA did not increase the radiation exposure and fluoroscopy time. This is in line with two aforementioned studies concerning this issue, 6, 8 however in contrary to general population undergoing PCI, where an increase in radiation exposure with TRA has been demonstrated. 20, 21 And finally, a hospital stay after RA via TRA was significantly shorter than via TFA, similar to Kassimis et al, 7 that matters also in terms of lowering health care costs.
In-hospital adverse events including death, MI and stroke were at low level and were comparable between the TRA and TFA group, in line with other observations concerning RA. Long-term outcomes were assessed only in one study 9 and there was no difference in the rates of death, MI or stroke between two study groups, what is in accordance with our 1-year follow-up.
Therefore, our analysis suggests that the use of RA via TRA might be more beneficial than via TFA. For this reason, following proper training and patient preparation, operators should not be afraid of performing complex PCI such as RA via TRA. TRA seems to be peculiarly crucial to octogenarians, especially nowadays, at overall aging population with more complex and calcified lesions. 22 These above mentioned findings warrant further confirmation in more extensive registries or randomized controlled trials.
| Study limitations
The study was an observational registry from a single high-volume center and nonrandomized. The sample size was relatively small and the analyses should be considered rather explorative. The construction FIGURE 2 Kaplan-Meier survival curves after rotational atherectomy, Log rank P = 0.43.
FIGURE 3
Kaplan-Meier major adverse cardiac event (MACE)-free survival curves after rotational atherectomy, Log rank P = 0.40. of the database did not allow us to assess the causes and frequency of crossover from TRA to TFA. Only all-cause mortality was reported during follow-up without differentiating the group of cardiac death patients.
| CONCLUSIONS
Even though RA is a complex and demanding technique, it is safer and more effective when performed via TRA. It allows to maintain the same procedural success and long-term results in comparison to TFA.
Moreover, the use of TRA reduces in-hospital adverse events, mainly major access site bleedings, lowers the amount of contrast media and shortens hospital stay. For these above mentioned reasons the routine use of TRA in RA procedures is recommended and should be encouraged.
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